XTX Topco Ltd Takes $285,000 Position in The Chemours Company (NYSE:CC)

XTX Topco Ltd bought a new position in The Chemours Company (NYSE:CC - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 21,063 shares of the specialty chemicals company's stock, valued at approximately $285,000.

Several other institutional investors have also recently bought and sold shares of the company. SG Americas Securities LLC bought a new stake in shares of Chemours in the 1st quarter valued at approximately $822,000. Principal Financial Group Inc. grew its stake in shares of Chemours by 116.3% in the 1st quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company's stock valued at $10,041,000 after purchasing an additional 399,097 shares during the period. Janney Montgomery Scott LLC grew its stake in shares of Chemours by 22.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 31,886 shares of the specialty chemicals company's stock valued at $431,000 after purchasing an additional 5,843 shares during the period. GAMMA Investing LLC grew its stake in shares of Chemours by 1,115.2% in the 1st quarter. GAMMA Investing LLC now owns 18,617 shares of the specialty chemicals company's stock valued at $252,000 after purchasing an additional 17,085 shares during the period. Finally, Bessemer Group Inc. grew its stake in shares of Chemours by 8.7% in the 1st quarter. Bessemer Group Inc. now owns 38,554 shares of the specialty chemicals company's stock valued at $522,000 after purchasing an additional 3,081 shares during the period. Institutional investors own 76.26% of the company's stock.

Chemours Price Performance

Shares of Chemours stock traded up $0.71 during midday trading on Tuesday, hitting $12.39. 2,768,111 shares of the company traded hands, compared to its average volume of 4,067,307. The stock has a market cap of $1.85 billion, a price-to-earnings ratio of -4.43 and a beta of 1.61. The company has a debt-to-equity ratio of 17.16, a quick ratio of 0.83 and a current ratio of 1.68. The firm's fifty day moving average price is $12.32 and its 200-day moving average price is $13.14. The Chemours Company has a 12 month low of $9.13 and a 12 month high of $22.38.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.12. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%. The company had revenue of $1.62 billion for the quarter, compared to analysts' expectations of $1.57 billion. During the same period in the previous year, the business posted $0.38 earnings per share. The business's quarterly revenue was up 5.0% compared to the same quarter last year. As a group, sell-side analysts forecast that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 15th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $0.35 dividend on an annualized basis and a yield of 2.8%. Chemours's dividend payout ratio is -12.50%.

Wall Street Analyst Weigh In

CC has been the topic of several research analyst reports. Royal Bank Of Canada upped their price objective on shares of Chemours from $14.00 to $15.00 and gave the stock an "outperform" rating in a research note on Thursday, July 3rd. UBS Group cut their price target on shares of Chemours from $18.00 to $17.00 and set a "buy" rating on the stock in a research note on Wednesday, May 7th. Barclays cut their target price on Chemours from $16.00 to $13.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 28th. Mizuho upped their target price on Chemours from $13.00 to $16.00 and gave the stock an "outperform" rating in a report on Tuesday, July 15th. Finally, The Goldman Sachs Group dropped their target price on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, Chemours presently has a consensus rating of "Hold" and an average price target of $17.38.

Insider Buying and Selling at Chemours

In other news, CFO Shane Hostetter bought 4,450 shares of the business's stock in a transaction that occurred on Monday, May 19th. The shares were bought at an average cost of $11.28 per share, for a total transaction of $50,196.00. Following the acquisition, the chief financial officer directly owned 59,694 shares in the company, valued at approximately $673,348.32. This trade represents a 8.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Damian Gumpel bought 7,822 shares of the company's stock in a transaction dated Tuesday, June 3rd. The stock was bought at an average price of $9.95 per share, for a total transaction of $77,828.90. Following the acquisition, the insider directly owned 131,701 shares of the company's stock, valued at approximately $1,310,424.95. This represents a 6.31% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 29,740 shares of company stock valued at $300,633. 0.34% of the stock is currently owned by insiders.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.